Back

Individual lifetime benefit from low-dose colchicine in chronic coronary artery disease patients

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Inflammation and coronary artery disease Pharmacotherapy ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Pascal Burger

University Medical Center Utrecht, Utrecht (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Immuno-inflammatory response in patients after myocardial infarction and involvement in fibrosis in vitro
Mrs A. Vinhais Da Silva (Tours, FR)
Abstract Slides Video
Presentation thumbnail
Level of vascular inflammation is higher in acute coronary syndromes compared to chronic coronary disease
Doctor T. Yonetsu (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Evaluating systemic immune-inflammation index for in-hospital and long-term mortality in elderly Non-ST elevation myocardial infarction patients
Associate Professor T. Cinar (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Association between high sensitivity c-reactive protein and coronary atherosclerosis in a general middle-aged population
Doctor S. Cederstrom (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Inflammation and coronary artery disease

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Lifetime risk in preventive treatment decisions: the clinical impact of using different prediction horizons to identify individuals at high risk of cardiovascular disease
thumbnail
Congress Presentation
Predicting cardiovascular risk: new horizons - discussion
thumbnail
Congress Presentation
Triple oral lipid-lowering treatment pathway and associated outcomes in high- and very high-cv risk patients: a simulation using the SANTORINI study cohort

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources